Literature DB >> 8549665

TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma: dependence on alpha 5 beta 1 and beta 2 integrins.

B Bauvois1, J Van Weyenbergh, D Rouillard, J Wietzerbin.   

Abstract

Monocyte migration within the extravascular space of inflamed tissues is controlled by adhesion molecules and inflammatory cytokines. In this study, we analyzed the capacity of TGF-beta 1 and IFN-gamma to regulate adhesion of human activated monocytes to fibronectin (FN) and to laminin (LM), two components of the extracellular matrix. When cultured in the absence of any of these two stimuli, human monocytes underwent "spontaneous activation" and adhered to both FN and LM. Adhesion to FN was inhibited in the presence of alpha 5 and beta 1 integrin blocking antibodies, whereas beta 2 blocking antibody blocked attachment to LM. Exogenous TGF-beta 1 increased the adhesive ability of monocytes to FN and to LM, respectively, linked to the increase of alpha 5 and beta 2 mRNA and protein synthesis levels. Moreover, an increase in alpha 5 expression at the monocyte cell surface was observed. In contrast, monocytes stimulated with exogenous IFN-gamma lost their capacity to bind to FN and this coincided with the down-regulation of surface alpha 5 expression which occurred at the posttranscriptional level of alpha 5 synthesis. Although IFN-gamma-treated monocytes also showed a decreased ability to adhere to LM, no alteration of beta 2 mRNA levels, beta 2 protein synthesis, and beta 2 cell surface expression was detectable, thus suggesting a modification of the functional state of surface beta 2 integrins. Furthermore, when stimulated with TGF-beta 1, IFN-gamma-pretreated monocytes reacquired the ability to bind to FN and LM. Conversely, IFN-gamma reduced adhesiveness to FN and LM of monocytes initially stimulated with TGF-beta 1. These in vitro adhesive-deadhesive responses of monocytes to TGF-beta 1 and IFN-gamma modulation may reflect mononuclear phagocyte motility within sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8549665     DOI: 10.1006/excr.1996.0026

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Beta 2 (CD18) and beta 1 (CD29) integrin mechanisms in migration of human polymorphonuclear leucocytes and monocytes through lung fibroblast barriers: shared and distinct mechanisms.

Authors:  X Z Shang; A C Issekutz
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

2.  gamma-Glutamyl transpeptidase expression in Ewing's sarcoma cells: up-regulation by interferons.

Authors:  Lena Bouman; Josiane Sancéau; Dany Rouillard; Brigitte Bauvois
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

3.  The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase.

Authors:  Angela F Messmer-Blust; Sujata Balasubramanian; Victoria Y Gorbacheva; Jonathan A Jeyaratnam; Deborah J Vestal
Journal:  Mol Biol Cell       Date:  2010-05-26       Impact factor: 4.138

4.  Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.

Authors:  Faten Merhi; Ruoping Tang; Marion Piedfer; Julie Mathieu; Isabelle Bombarda; Murhaf Zaher; Jean-Pierre Kolb; Christian Billard; Brigitte Bauvois
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

5.  Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.

Authors:  B Bauvois; I De Meester; J Dumont; D Rouillard; H X Zhao; E Bosmans
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

6.  Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.

Authors:  Marion Piedfer; Daniel Dauzonne; Ruoping Tang; Juliette N'Guyen; Christian Billard; Brigitte Bauvois
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.